5 Big Pharma Stocks With the Best Drug Pipelines

5 Big Pharma Stocks With the Best Drug Pipelines

Big pharma companies can't rest on their laurels. Continual research and development is critical to ensure long-term success. Some of that R&D pays off more than others, though.

Market research firm EvaluatePharma recently released its report looking at the state of the biopharmaceutical industry five years from now. One key area the firm researched was the potential value creation from pipeline products between now and 2022. Here's why Roche (NASDAQOTH: RHHBY), AstraZeneca (NYSE: AZN), AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ) ranked at the top.

Image source: Getty Images.

Continue reading

Source: Fool.com